Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2020-05-11 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于取得医疗器械注册证暨医疗器械注册变更的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from 三诺生物传感股份有限公司 regarding the receipt and changes of medical device registration certificates issued by the Hunan Provincial Drug Administration. It lists specific registration certificates obtained or changed, their validity periods, product names, and intended uses. The document is a regulatory announcement about product certifications and does not contain financial data, management discussion, or detailed financial reports. It is not a report itself but an announcement of regulatory compliance and product registration updates. The document length is under 5,000 characters and primarily serves as a formal disclosure to investors about regulatory approvals and changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-11 Chinese
2019年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement from 三诺生物传感股份有限公司 regarding the implementation of the 2019 annual equity distribution (dividend payment) plan. It details the dividend amount per share, the record date, the ex-dividend date, the total dividend amount, and the method of dividend distribution. It references the approval of the dividend plan at the 2019 annual general meeting and provides specifics on the dividend payment process and tax treatment. The document is relatively short (3381 characters) and focuses on the implementation of a dividend distribution rather than presenting a full financial report or detailed financial statements. It does not contain comprehensive financial data or management discussion but is an official announcement of the dividend payment details. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2020-05-11 Chinese
2019年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a 2019 Annual General Meeting (AGM) resolution announcement for 三诺生物传感股份有限公司. It details the meeting date, voting methods, attendance, and the voting results on various proposals including the 2019 annual report, financial statements, profit distribution plan, amendments to the company articles, and remuneration plans. It also includes legal opinions on the meeting's validity. The document is focused on the resolutions passed at the AGM rather than the full annual report or financial statements themselves. The content is consistent with an official announcement of voting results from a shareholder meeting. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4859 characters, which is sufficient to include detailed voting results rather than just a brief announcement of report publication (RPA).
2020-05-07 Chinese
关于公司高级管理人员减持计划的预披露公告
Director's Dealing Classification · 100% confidence The document is a pre-disclosure announcement regarding a senior management personnel's plan to reduce their shareholding in the company. It details the planned share reduction by the company's board secretary and CFO, including the number of shares, percentage of total shares, reasons for reduction, and compliance with relevant regulations. There are no financial statements, earnings data, or report attachments. The document is a notification about a director's personal share transaction plan, which fits the definition of Director's Dealing (DIRS). The document length is short and focused solely on the insider share sale plan, confirming it is not a full report or announcement of a report publication.
2020-05-07 Chinese
2019年年度股东大会的法律意见书
Regulatory Filings
2020-05-07 Chinese
关于回购公司部分股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase program. It details the number of shares repurchased, prices, compliance with regulations, and the timeline of the repurchase plan. It does not contain financial statements or earnings data, nor is it a full report or presentation. The document is a formal update on the company's share buyback activity, which fits the definition of a Transaction in Own Shares (POS) filing. The document length is relatively short (2163 characters), but it contains substantive information about the repurchase progress, not just a notice of report publication or a certification. Therefore, the correct classification is POS.
2020-05-06 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.